HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 2, 2014, Pages

  Demos Davies, Kimberly M ^a   Ferguson, Bradley S ^a   Cavasin, Maria A ^a   Mahaffey, Jennifer H ^a   Williams, Sarah M ^b   Spiltoir, Jessica I ^a   Schuetze, Katherine B ^a   Horn, Todd R ^b   Chen, Bo ^a   Ferrara, Claudia ^c   Scellini, Beatrice ^c   Piroddi, Nicoletta ^c   Tesi, Chiara ^c   Poggesi, Corrado ^c   Jeong, Mark Y ^a   McKinsey, Timothy A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cardiac dysfunction; Deacetylase; Muscle atrophy

Indexed keywords

ANGIOTENSIN II; HISTONE DEACETYLASE 6 INHIBITOR; HISTONE DEACETYLASE INHIBITOR; TUBASTATIN A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD PRESSURE REGULATION; CARDIAC DYSFUNCTION; CONTROLLED STUDY; DRUG RESPONSE; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TREATMENT DURATION; WILD TYPE;

CARDIAC DYSFUNCTION; DEACETYLASE; MUSCLE ATROPHY;

ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; DISEASE MODELS, ANIMAL; FIBROSIS; HEART FAILURE; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; INDOLES; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOCARDIUM; SIGNAL TRANSDUCTION; STROKE VOLUME; SYSTOLE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84904293106     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00149.2014     Document Type: Article

References (22)

1. Alamdari N, Smith IJ, Aversa Z, Hasselgren PO. Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 299: R509-R520, 2010.
2. Butler KV, Kalin J, Brochier C, Vistoli G, Langley B, Kozikowski AP. Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc 132: 10842-10846, 2010.
3. Cabello-Verrugio C, Cordova G, Salas JD. Angiotensin II: role in skeletal muscle atrophy. Curr Protein Pept Sci 13: 560-569, 2012.
4. Cohen TJ, Waddell DS, Barrientos T, Lu Z, Feng G, Cox GA, Bodine SC, Yao TP. The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J Biol Chem 282: 33752-33759, 2007.
5. Di Bari M, van de Poll-Franse LV, Onder G, Kritchevsky SB, Newman A, Harris TB, Williamson JD, Marchionni N, Pahor M. Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study. J Am Geriatr Soc 52: 961-966, 2004.
6. Di Fulvio S, Azakir BA, Therrien C, Sinnreich M. Dysferlin interacts with histone deacetylase 6 and increases alpha-tubulin acetylation. PLoS One 6: e28563, 2011.
7. Gao YS, Hubbert CC, Lu J, Lee YS, Lee JY, Yao TP. Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis. Mol Cell Biol 27: 8637-8647, 2007.
8. Gregoretti IV, Lee YM, Goodson HV. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol 338: 17-31, 2004.
9. Herzog EL, Bucala R. Fibrocytes in health and disease. Exp Hematol 38: 548-556, 2010.
10. Lee JY, Koga H, Kawaguchi Y, Tang W, Wong E, Gao YS, Pandey UB, Kaushik S, Tresse E, Lu J, Taylor JP, Cuervo AM, Yao TP. HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO J 29: 969-980, 2010.
11. Lemon DD, Horn TR, Cavasin MA, Jeong MY, Haubold KW, Long CS, Irwin DC, McCune SA, Chung E, Leinwand LA, McKinsey TA. Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension. J Mol Cell Cardiol 51: 41-50, 2011.
12. McKinsey TA. Derepression of pathological cardiac genes by members of the CaM kinase superfamily. Cardiovasc Res 73: 667-677, 2007.
13. Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, McAnally J, Shelton JM, Backs J, Klein WH, Richardson JA, Bassel-Duby R, Olson EN. Myogenin and class-II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 143: 35-45, 2010.
14. Onder G, Penninx BW, Balkrishnan R, Fried LP, Chaves PH, Williamson J, Carter C, Di BM, Guralnik JM, Pahor M. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet 359: 926-930, 2002.
15. 2+ transients in isolated bundles of skeletal muscle fibers from rats with chronic heart failure. Circ Res 73: 405-412, 1993.
16. Piepoli MF, Guazzi M, Boriani G, Cicoira M, Corra U, Dalla LL, Emdin M, Mele D, Passino C, Vescovo G, Vigorito C, Villani GQ, Agostoni P. Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I. Eur J Cardiovasc Prev Rehabil 17: 637-642, 2010.
17. Piroddi N, Belus A, Scellini B, Tesi C, Giunti G, Cerbai E, Mugelli A, Poggesi C. Tension generation and relaxation in single myofibrils from human atrial and ventricular myocardium. Pflügers Arch 454: 63-73, 2007.
18. Shearer F, Lang CC, Struthers AD. Renin-angiotensin-aldosterone system inhibitors in heart failure. Clin Pharmacol Ther 94: 459-467, 2013.
19. Sukhanov S, Semprun-Prieto L, Yoshida T, Michael TA, Higashi Y, Galvez S, Delafontaine P. Angiotensin II, oxidative stress and skeletal muscle wasting. Am J Med Sci 342: 143-147, 2011.
20. Tang H, Macpherson P, Marvin M, Meadows E, Klein WH, Yang XJ, Goldman D. A histone deacetylase 4/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression. Mol Biol Cell 20: 1120-1131, 2009.
21. Williams SM, Golden-Mason L, Ferguson BS, Schuetze KB, Cavasin MA, Demos-Davies K, Yeager ME, Stenmark KR, McKinsey TA. Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes. J Mol Cell Cardiol 67: 112-125, 2014.
22. Zhang D, Wu CT, Qi X, Meijering RA, Hoogstra-Berends F, Tadevosyan A, Cubukcuoglu DG, Durdu S, Akar AR, Sibon OC, Nattel S, Henning RH, Brundel BJ. Activation of histone deacetylase-6 induces contractile dysfunction through derailment of alpha-tubulin proteostasis in experimental and human atrial fibrillation. Circulation 129: 346-358, 2014.